Next, we analyzed the levels of PAK5 at different tumor/node/metastasis (TNM) stages and discovered that PAK5 expression in stage III/IV was much higher than those in stage I/II, suggesting a correlation of PAK5 with CRC tumor progression (Figure 1E). This evidence concerns the gene PAK5 and neoplasm.